Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Platelet activation marker].

Shosaku Nomura1

  • 1First Department of Internal Medicine, Kansai Medical University, Moriguchi 570-8507.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|December 19, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of the P2X<sub>3</sub> Antagonist Gefapixant for Refractory Atopic Cough: A Retrospective Cohort Study.

Journal of asthma and allergy·2026
Same author

Can tiotropium add-on inhalation revolutionize therapy in elderly asthmatic patients? A treatable traits approach towards successful aging.

International journal of clinical pharmacology and therapeutics·2026
Same author

Risk of Atherosclerosis Due to HMGB1-dependent Platelet-derived Microparticles in Patients with Type 2 Diabetes Mellitus.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2024
Same author

Current Status and Challenges in Delivering Comprehensive Care for Patients with Hemophilia.

Journal of blood medicine·2023
Same author

Efficacy of Gefapixant, a P2X<sub>3</sub> Antagonist, for Refractory Atopic Cough.

International medical case reports journal·2023
Same author

Real-world data on induction therapy in patients with transplant-ineligible newly diagnosed multiple myeloma: retrospective analysis of 598 cases from Kansai Myeloma Forum.

International journal of hematology·2023
Same journal

[The Role of Laboratory Medicine in Hematopoietic Stem Cell Transplantation "Echocardiogram"].

Rinsho byori. The Japanese journal of clinical pathology·2019
Same journal

[The Significance of Pulmonary Function Testing Before and After Allogeneic Stem Cell Transplantation].

Rinsho byori. The Japanese journal of clinical pathology·2019
Same journal

[Blood Transfusion Inspection].

Rinsho byori. The Japanese journal of clinical pathology·2019
Same journal

[The Role of Clinical Laboratory Technicians at Bone Marrow Transplantation : Blood Test].

Rinsho byori. The Japanese journal of clinical pathology·2019
Same journal

[The Foundation of Allogeneic Hematopoietic Stem Cell Transplantation and the Role of Clinical Laboratory Tests in This Field].

Rinsho byori. The Japanese journal of clinical pathology·2019
Same journal

[How to Interpret Data from Routine Laboratory Tests].

Rinsho byori. The Japanese journal of clinical pathology·2019
See all related articles

Diabetic patients show elevated platelet activation markers and platelet-derived microparticles (PDMP), contributing to atherosclerosis. These markers may help assess vascular damage in diabetes.

Area of Science:

  • Cardiovascular Medicine
  • Diabetology
  • Hematology

Context:

  • Atherosclerosis is a major cause of mortality in diabetes mellitus.
  • Traditional risk factors do not fully explain the increased atherosclerosis incidence in diabetic patients.
  • Diabetic platelets exhibit heightened aggregation sensitivity and elevated activation markers.

Purpose:

  • To investigate the role of platelet activation markers and platelet-derived microparticles (PDMP) in diabetes-associated atherosclerosis.
  • To explore the relationship between platelet activation, shear stress, and PDMP generation in diseased vasculature.
  • To assess the utility of platelet activation markers in evaluating vascular damage in diabetic individuals.

Summary:

  • Elevated platelet activation markers (CD62P, CD63, PAC-1, Annexin V) and PDMP are observed in diabetes.

Related Experiment Videos

  • PDMP, expressing procoagulant phospholipids, are implicated in disease pathogenesis.
  • High shear stress induces platelet aggregation and PDMP shedding, relevant to microvascular conditions.
  • Platelet activation markers and PDMP may contribute to atherosclerosis development in diabetes.

    • Impact:

    • Platelet activation markers may serve as valuable indicators for assessing vascular damage in diabetic patients.
    • Understanding PDMP's role can inform strategies for managing atherosclerosis in diabetes.
    • This research highlights the complex interplay between platelet function and cardiovascular complications in diabetes.